secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001437749-24-021302
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics stockholders approve 5M share increase to 2015 Incentive Plan
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2015 Incentive Plan, increasing authorized shares by 5,000,000.
- Plan term extended to June 24, 2034; non-employee director annual limit increased to 500,000 shares.
- All six director nominees elected; KPMG ratified as auditor for FY2024.
- Total shares reserved under the plan after amendment: 5,070,223.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/0001437749-24-021302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000143774924021302/atxi20240625_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-021302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer